GB1205083A - Improvements in or relating to lineomycin derivatives and the manufacture thereof - Google Patents
Improvements in or relating to lineomycin derivatives and the manufacture thereofInfo
- Publication number
- GB1205083A GB1205083A GB08148/68A GB1814868A GB1205083A GB 1205083 A GB1205083 A GB 1205083A GB 08148/68 A GB08148/68 A GB 08148/68A GB 1814868 A GB1814868 A GB 1814868A GB 1205083 A GB1205083 A GB 1205083A
- Authority
- GB
- United Kingdom
- Prior art keywords
- hydrocarbonoxycarbonyl
- formula
- derivatives
- compounds
- lincomycin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
- C07H15/16—Lincomycin; Derivatives thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
1,205,083. Lincomycin derivatives. UPJOHN CO. 17 April, 1968 [10 May, 1967], No. 18148/68. Heading C2C. Novel compounds of the Formula (I) are prepared by condensing compounds of the Formula (II) with appropriate aldehydes to give compounds of the Formula (III), acylating these to give compounds of the Formula (IV) and removing the acetal and, when necessary, the N-protecting groups. R 2 CO is an optionally substituted hydrocarbon carboxylic acyl radical of up to 18 carbon atoms or an alkoxycarbonyl group; X is Cl or Br; R and HR 1 are each C 1-20 alkyl, C 3-8 cycloalkyl or C 7-12 aralkyl; R 3 is H, C 1-20 alkyl, C 3-8 cycloalkyl or optionally substituted C 7-12 aralkyl; and Q is a protecting group, such as one removable by hydrogenolysis, e.g. hydrocarbonoxycarbonyl, benzyl or nitrobenzyl, or is R 3 other than H. Also claimed as novel are (IV), where Q is R 3 other than H or is hydrocarbonoxycarbonyl, (III) where Q is hydrocarbonoxycarbonyl, benzyl or nitrobenzyl and (I) where R 3 is additionally hydrocarbonoxycarbonyl. The lincomycin derivatives (I) have essentially the same antibacterial activity as lincomycin and can be made up into pharmaceutical compositions with suitable carriers. Thus, aqueous formulations can be used in pediatrics. Specifications 1,140,663 and 1,140,833 are referred to.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63735867A | 1967-05-10 | 1967-05-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1205083A true GB1205083A (en) | 1970-09-16 |
Family
ID=24555584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08148/68A Expired GB1205083A (en) | 1967-05-10 | 1968-04-17 | Improvements in or relating to lineomycin derivatives and the manufacture thereof |
Country Status (8)
Country | Link |
---|---|
BE (1) | BE714980A (en) |
CA (1) | CA918652A (en) |
CH (1) | CH534692A (en) |
DE (3) | DE1795847C2 (en) |
FR (2) | FR1592113A (en) |
GB (1) | GB1205083A (en) |
IL (1) | IL29801A (en) |
NL (1) | NL151379B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100368419C (en) * | 2006-03-01 | 2008-02-13 | 重庆凯林制药有限公司 | Industrial production process of palmitate of clindamycin hydrochloride |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2230427C2 (en) * | 1971-06-23 | 1984-05-10 | The Upjohn Co., Kalamazoo, Mich. | Clindamycin analogs and processes for their preparation |
-
1968
- 1968-03-21 CA CA015496A patent/CA918652A/en not_active Expired
- 1968-04-10 IL IL29801A patent/IL29801A/en unknown
- 1968-04-17 GB GB08148/68A patent/GB1205083A/en not_active Expired
- 1968-04-26 CH CH622268A patent/CH534692A/en not_active IP Right Cessation
- 1968-05-08 DE DE1795847A patent/DE1795847C2/en not_active Expired
- 1968-05-08 NL NL686806513A patent/NL151379B/en not_active IP Right Cessation
- 1968-05-08 DE DE1795846A patent/DE1795846C2/en not_active Expired
- 1968-05-08 DE DE1770351A patent/DE1770351C2/en not_active Expired
- 1968-05-09 FR FR1592113D patent/FR1592113A/fr not_active Expired
- 1968-05-10 BE BE714980D patent/BE714980A/xx not_active IP Right Cessation
- 1968-08-08 FR FR162418A patent/FR7914M/fr not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100368419C (en) * | 2006-03-01 | 2008-02-13 | 重庆凯林制药有限公司 | Industrial production process of palmitate of clindamycin hydrochloride |
Also Published As
Publication number | Publication date |
---|---|
NL151379B (en) | 1976-11-15 |
DE1795846A1 (en) | 1977-02-24 |
DE1795846C2 (en) | 1983-12-22 |
IL29801A (en) | 1971-10-20 |
DE1770351A1 (en) | 1971-10-21 |
FR7914M (en) | 1970-05-11 |
BE714980A (en) | 1968-11-12 |
NL6806513A (en) | 1968-11-11 |
CH534692A (en) | 1973-03-15 |
DE1795847A1 (en) | 1977-02-24 |
DE1795847C2 (en) | 1983-10-27 |
FR1592113A (en) | 1970-05-11 |
CA918652A (en) | 1973-01-09 |
IL29801A0 (en) | 1968-06-20 |
DE1770351C2 (en) | 1983-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1426908A (en) | 1-n--s--alpha-hydroxy-omega-aminoacyl- derivative of amino glycosidic antibiotics | |
GB1506934A (en) | Derivatives of 3-amino-dihydrothiophen-2-one | |
GB1249425A (en) | Acylated glucopyranoside derivatives | |
IE42179L (en) | Kanamycin derivatives | |
IE32453L (en) | Pteridine derivatives | |
GB1205083A (en) | Improvements in or relating to lineomycin derivatives and the manufacture thereof | |
GB1129158A (en) | Coronary dilating compositions | |
GB1457707A (en) | Bicyclic hindered amino acids and their salts as stabilisers | |
ES374291A1 (en) | 6 7-diacyloxy-tetrahydroisoquinoline compounds | |
ES375079A1 (en) | 3-alkoxy-or 3-aryloxy-2-(diaryl-hydroxy)-methyl-propylamines | |
GB1250558A (en) | ||
ES447307A1 (en) | Novel process for the preparation of 1-N-(alpha-substituted-omega-aminoacyl)-3{40 -deoxyribostamycin | |
GB1215899A (en) | Novel benztriazine derivatives and process for preparing the same | |
NL6813094A (en) | Tetramycin antibiotic | |
GB1325237A (en) | Esters and their preparation | |
IE34826L (en) | Neriifolin derivatives. | |
ES373657A1 (en) | Di-hydro triazine derivatives and processes for their manufacture | |
GB1420533A (en) | Pyridine derivatives having juvenile hormone activity | |
GB1273399A (en) | Novel formamido-cycloalkane derivatives | |
IE34081B1 (en) | Butanolamine derivatives | |
GB1269291A (en) | Improvements in or relating to corticoid carbonates | |
GB1471371A (en) | Cyclopenteno-b-pyridine derivative | |
GB1347382A (en) | Halobenzylamine compounds and their production | |
ES347230A1 (en) | Estratrienes, Processes for their Preparation, and Compositions Incorporating them | |
GB1390650A (en) | Oxazines and thiazines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PE20 | Patent expired after termination of 20 years |